期刊文献+

多肽介导靶向的药物纳米制剂 被引量:1

Peptide-mediated Nanoformulation for Drug Targeting Delivery
原文传递
导出
摘要 多肽介导靶向的药物纳米制剂是将多肽靶向分子引入纳米载体表面的一种主动靶向药物制剂,可增加药物到达肿瘤组织和导入肿瘤细胞的量,实现有效治疗肿瘤的目标。本文概括性地介绍了本课题组在多肽介导靶向的药物纳米制剂方面开展的部分研究工作,包括多肽靶向分子稳定化策略和拼接策略,以及多肽介导靶向的新型纳米制剂等。 By modifying peptide targeted molecule onto the surface of nanocarrier,polypeptide-mediated nanoformulation could increase drug accumulation in tumor tissues and uptake of tumor cells,so as to obtain effective tumor treatment.In this paper,we briefly introduce the studies on peptide-mediated nanoformulation by our research group,including peptide stabilization strategies,peptide linkage modes and novel peptide-mediated nanoformulations.
作者 刘敏 张芷依 陆伟跃 LIU Min;ZHANG Zhiyi;LU Weiyue(School of Pharmacy,Fudan University,Shanghai 201203)
机构地区 复旦大学药学院
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2019年第10期1085-1097,共13页 Chinese Journal of Pharmaceuticals
基金 国家重大科学研究计划(973)(2013CB932500) 国家自然科学基金重大项目(81690263) 国家自然科学基金面上项目(81773657) 上海市教育委员会科研创新计划项目重大项目(2017-01-07-00-07-E00052)
关键词 多肽靶向分子 纳米载体 药物制剂 靶向递药 peptide targeted molecule nanocarrier drug formulation targeting drug delivery
  • 相关文献

参考文献3

二级参考文献123

  • 1Pardeike J, Mtiller RH. Nanosuspensions:a promising formulation for the new phospholipase A2 inhibitor PX-18 [ J ]. Int J Pharm, 2010,391 (1/2) :322 -329.
  • 2Shegokar R, MUller RH. Nanocrystals:industrially feasible multi- functional formulation technology for poorly soluble actives [ J ]. lnt J Pharm,2010,399(1/2) : 129 - 139.
  • 3Rabinow BE. Nanosuspensions in drug delivery[J]. Nat Rev Drug Discov, 2004,3 ( 9 ) : 785 - 796.
  • 4Chaubal MV, Popescu C. Conversion of nanosuspensions into dry powders by spray drying: a case study[J]. Pharm Res,2008,25 (10) :2 302 -2 308.
  • 5Beirowski J, Inghelbrecht S, Arien A, et al. Freeze-drying of nanosuspensions, 1: freezing rate versus formulation design as critical factors to preserve the original particle size distribution [J]. Int J Pharm,2011,100(5) :1 958 - 1 968.
  • 6Bose S, Sshenck D, Ghosh I, et al. Application of spray granula- tion for conversion of a nanosuspension into a dry powder form [J]. Eur J Pharm Sci,2012,47( 1 ) :35 -43.
  • 7Mailer RH, Gohla S, Keck CM. State of the art of nanocrystals - Special features, production, nanotoxicology aspects and intracellular delivery [ J ]. Eur J Pharm Biopharm 2011,78 ( 1 ) : 1-9.
  • 8Verma S, Gokhale R, Burgess DJ. A comparative study of top- down and bottom-up approaches for the preparation of micro/ nanosuspensions [ J J. Int J Pharm,2009,380 (12) :216 - 222.
  • 9Gao L, Zhang DR, Chen MH. Drug nanocrystals for the formula- tion of poorly soluble drugs and its application as a potential drug delivery system [ J ]. J Nanopart Res,2008,10 ( 5 ) : 845 - 862.
  • 10Peltonen L, Hirvonen J. Pharmaceutical nanocrystals by nanomill- ing:critical process parameters, particle fracturing and stabiliza- tion methods [ J ]. J Pharm Pharmacol, 2010,62 ( 11 ) : 1 569 - 1 579.

共引文献21

同被引文献15

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部